JP2005525397A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2005525397A5 JP2005525397A5 JP2003583443A JP2003583443A JP2005525397A5 JP 2005525397 A5 JP2005525397 A5 JP 2005525397A5 JP 2003583443 A JP2003583443 A JP 2003583443A JP 2003583443 A JP2003583443 A JP 2003583443A JP 2005525397 A5 JP2005525397 A5 JP 2005525397A5
- Authority
- JP
- Japan
- Prior art keywords
- tumor
- therapeutic agent
- agent according
- solid tumor
- solid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 206010028980 Neoplasm Diseases 0.000 claims 10
- 239000003814 drug Substances 0.000 claims 8
- 229940124597 therapeutic agent Drugs 0.000 claims 8
- 206010006187 Breast cancer Diseases 0.000 claims 1
- 208000026310 Breast neoplasm Diseases 0.000 claims 1
- 206010061968 Gastric neoplasm Diseases 0.000 claims 1
- 208000008839 Kidney Neoplasms Diseases 0.000 claims 1
- 206010061535 Ovarian neoplasm Diseases 0.000 claims 1
- 239000004480 active ingredient Substances 0.000 claims 1
- 210000000481 breast Anatomy 0.000 claims 1
- 201000011510 cancer Diseases 0.000 claims 1
- 210000001072 colon Anatomy 0.000 claims 1
- 208000029742 colonic neoplasm Diseases 0.000 claims 1
- 210000003734 kidney Anatomy 0.000 claims 1
- 210000001672 ovary Anatomy 0.000 claims 1
- 210000002307 prostate Anatomy 0.000 claims 1
- 208000023958 prostate neoplasm Diseases 0.000 claims 1
- PTLRDCMBXHILCL-UHFFFAOYSA-M sodium arsenite Chemical compound [Na+].[O-][As]=O PTLRDCMBXHILCL-UHFFFAOYSA-M 0.000 claims 1
- 210000002784 stomach Anatomy 0.000 claims 1
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/NL2002/000231 WO2003086424A1 (en) | 2002-04-10 | 2002-04-10 | Pharmaceutical composition comprising arsenite for the treatment of malignancy |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2005525397A JP2005525397A (ja) | 2005-08-25 |
| JP2005525397A5 true JP2005525397A5 (cg-RX-API-DMAC7.html) | 2008-06-26 |
Family
ID=29244880
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2003583443A Pending JP2005525397A (ja) | 2002-04-10 | 2002-04-10 | 悪性腫瘍の処置のための亜ヒ酸塩を含む薬学的組成物 |
Country Status (25)
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2006024492A2 (en) * | 2004-08-30 | 2006-03-09 | Interstitial Therapeutics | Medical implant provided with inhibitors of atp synthesis |
| EP1721615A1 (en) | 2005-05-09 | 2006-11-15 | Komipharm International Co., Ltd. | Pharmaceutical compositions comprising sodium or potassium arsenite for the treatment of urogenital cancer and its metastasis |
| US8945505B2 (en) | 2007-02-02 | 2015-02-03 | Panaphix, Inc. | Use of arsenic compounds for treatment of pain and inflammation |
| US20090246291A1 (en) * | 2008-03-27 | 2009-10-01 | Angelika Burger | Method and compositions for treatment of cancer |
| US20100249210A1 (en) * | 2008-09-30 | 2010-09-30 | Michael Bastiani | Methods and compositions related to dlk-1 and the p38 mapk pathway in nerve regeneration |
| CN102060722B (zh) * | 2009-05-01 | 2014-06-11 | 常州高新技术产业开发区三维工业技术研究所有限公司 | 一种含砷化合物及其制备方法和用途 |
| CA2772411C (en) * | 2009-09-10 | 2017-08-22 | Kominox, Inc. | Cancer stem cell-targeted and drug resistant cancer therapy |
| EP2477635A4 (en) * | 2009-09-18 | 2013-03-27 | Kominox Inc | METHODS OF TREATING CEREBRAL TUMORS |
| CN101695501B (zh) * | 2009-10-10 | 2013-08-14 | 广汉恒宇新材料有限公司 | 一种纳米尺寸亚砷酸的壳聚糖包载体及其制造方法 |
| KR102868121B1 (ko) | 2018-03-22 | 2025-10-14 | 코미팜 인터내셔널 오스트레일리아 피티와이 엘티디 | 메타 아비산염을 포함하는 약학 조성물 및 제조 방법 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0804928B1 (en) * | 1994-02-18 | 2004-10-20 | Tamara Vasilievna Vorobieva | Agent having an immunomodulating effect and reducing disturbed functioning of the tissue cell propagation regulating system |
| US6875451B2 (en) * | 1997-10-15 | 2005-04-05 | Polarx Biopharmaceuticals Inc. | Compositions and methods for the treatment of primary and metastatic neoplastic diseases using arsenic compounds |
| CN1119152C (zh) * | 1998-08-02 | 2003-08-27 | 哈尔滨医科大学第一临床医学院 | 治疗消化系统肿瘤注射液及其应用 |
-
2002
- 2002-04-10 WO PCT/NL2002/000231 patent/WO2003086424A1/en not_active Ceased
- 2002-04-10 EP EP08168243.7A patent/EP2042182B1/en not_active Expired - Lifetime
- 2002-04-10 BR BR0215689-0A patent/BR0215689A/pt not_active Application Discontinuation
- 2002-04-10 HU HU0500199A patent/HU230851B1/hu unknown
- 2002-04-10 IL IL16447002A patent/IL164470A0/xx unknown
- 2002-04-10 PT PT81682437T patent/PT2042182E/pt unknown
- 2002-04-10 LT LTEPPCT/NL2002/000231T patent/LT1496918T/lt unknown
- 2002-04-10 AU AU2002253713A patent/AU2002253713B2/en not_active Expired
- 2002-04-10 RO ROA200400890A patent/RO123269B1/ro unknown
- 2002-04-10 AP APAP/P/2004/003167A patent/AP2004003167A0/en unknown
- 2002-04-10 NZ NZ536452A patent/NZ536452A/en not_active IP Right Cessation
- 2002-04-10 CN CNB028287215A patent/CN1298332C/zh not_active Expired - Lifetime
- 2002-04-10 ES ES08168243T patent/ES2425418T3/es not_active Expired - Lifetime
- 2002-04-10 FI FIEP02722968.1T patent/FI1496918T3/fi active
- 2002-04-10 PT PT27229681T patent/PT1496918T/pt unknown
- 2002-04-10 DK DK08168243.7T patent/DK2042182T3/da active
- 2002-04-10 MX MXPA04009898A patent/MXPA04009898A/es unknown
- 2002-04-10 JP JP2003583443A patent/JP2005525397A/ja active Pending
- 2002-04-10 ES ES02722968T patent/ES2944907T3/es not_active Expired - Lifetime
- 2002-04-10 CA CA2481602A patent/CA2481602C/en not_active Expired - Lifetime
- 2002-04-10 DK DK02722968.1T patent/DK1496918T3/da active
- 2002-04-10 EP EP02722968.1A patent/EP1496918B1/en not_active Expired - Lifetime
- 2002-10-04 UA UA20041109151A patent/UA80426C2/uk unknown
-
2004
- 2004-10-08 TN TNP2004000198A patent/TNSN04198A1/en unknown
- 2004-10-08 US US10/962,357 patent/US20050106262A1/en not_active Abandoned
- 2004-10-10 IL IL164470A patent/IL164470A/en active IP Right Grant
- 2004-10-22 NO NO20044573A patent/NO335317B1/no not_active IP Right Cessation
- 2004-11-04 EC EC2004005408A patent/ECSP045408A/es unknown
- 2004-11-09 BG BG108932A patent/BG66356B1/bg unknown
-
2008
- 2008-12-04 AU AU2008255139A patent/AU2008255139B2/en not_active Expired
-
2013
- 2013-08-21 CY CY20131100715T patent/CY1114422T1/el unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2008526765A5 (cg-RX-API-DMAC7.html) | ||
| DE602005026789D1 (de) | Le | |
| NO2017019I2 (no) | Enzalutamid eller et farmasøytisk akseptabelt salt derav | |
| EP1535610A4 (en) | THERAPEUTIC CANCER | |
| JP2005525397A5 (cg-RX-API-DMAC7.html) | ||
| WO2008045604A3 (en) | Efficient synthesis of chelators for nuclear imaging and radiotherapy: compositions and applications | |
| NZ511938A (en) | Use of AT-1 receptor antagonist or treating diseases associated with an increase of AT-1 receptor | |
| MX2009006742A (es) | Inhibidores acilaminopirazoles como fgfr. | |
| JP2005525345A5 (cg-RX-API-DMAC7.html) | ||
| JP2004504381A5 (cg-RX-API-DMAC7.html) | ||
| GB0121490D0 (en) | Ciompounds | |
| NO20042035L (no) | Forbedret anvendelse av antitumorforbindelse i kreftterapi | |
| AU2003219555A8 (en) | Depsipeptide for therapy of kidney cancer | |
| RU2005129273A (ru) | Противораковый агент, содержащий белок lk8 в качестве активного ингредиента | |
| NO20040516L (no) | Kombinasjonsterapi for behandling av kreft. | |
| WO2006021412A3 (en) | Use of peptide compounds for treating bone cancer pain, chemotherapy-and nucleoside-induced pain | |
| TNSN07294A1 (en) | Treatment of metastasized tumors | |
| NO20050428L (no) | Arylkarbonylpiperaziner og heteroarylkarbonylpiperaziner og anvendelse derav for behandling av godartede og ondartede tumorsykdommer | |
| EP1667716B8 (en) | Cytotoxicity mediation of cells evidencing surface expression of cd44 | |
| RU2225710C2 (ru) | Списулозиновые соединения, обладающие противоопухолевой активностью | |
| EP2722060A3 (en) | Guanylyl cyclase C ligands | |
| FI1496918T3 (fi) | Natriummeta-arseniitin käyttö kasvainten hoidossa | |
| NO20055307D0 (no) | Substituerte isokromanforbindelser for behandling av metabolske forstyrrelser, kreft og andre sykdommer | |
| CN114401749A (zh) | 一种放射性核素标记物及其应用 | |
| JP2007508316A5 (cg-RX-API-DMAC7.html) |